Percheron Therapeutics Ltd (PER) — Capital Reinvestment Ratio

Latest as of September 2015: 0.01x

Percheron Therapeutics Ltd (PER) has a Capital Reinvestment Ratio of 0.01x as of September 2015, meaning it reinvests 0% of its operating cash flow (AU$317.22K) in capital expenditures (AU$1.90K). See net asset quality index of Percheron Therapeutics Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

AU$317.22K
AUD

Capital Expenditures

AU$1.90K
AUD

Data as of

Sep 2015
Most recent filing

Percheron Therapeutics Ltd Capital Reinvestment Ratio (2015–2015)

This chart tracks Percheron Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Percheron Therapeutics Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Percheron Therapeutics Ltd (2015–2015)

Year-by-year Capital Reinvestment Ratio for Percheron Therapeutics Ltd from 2015 to 2015. For live market cap and broader valuation context, see market cap of Percheron Therapeutics Ltd.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2015 0.00x AU$1.27 Million AU$3.86K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow